Abiopharma

FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimers Disease

New Form 8-K - Surrozen, Inc./DE Filed: 2025-08-29 AccNo: 0000950170-25-112253 Size: 815 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 424B5 - Surrozen, Inc./DE Filed: 2025-08-29 AccNo: 0000950170-25-112251 Size: 622 KB

Director Gaslightwala Abizer 🟢 acquired 21.0K shares of Akari Therapeutics Plc (AKTX) at $0.94 Transaction Date: Aug 21, 2025 | Filing ID: 026025

New Form 144 - Inspire Medical Systems, Inc. Filed: 2025-08-29 AccNo: 0001000275-25-000120 Size: 6 KB

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

New Form 8-K - Vaxart, Inc. Filed: 2025-08-29 AccNo: 0001437749-25-028047 Size: 183 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - ARTELO BIOSCIENCES, INC. Filed: 2025-08-29 AccNo: 0001640334-25-001613 Size: 151 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Sonoma Pharmaceuticals, Inc. Filed: 2025-08-29 AccNo: 0001683168-25-006580 Size: 202 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 144 - INTUITIVE SURGICAL INC Filed: 2025-08-29 AccNo: 0001950047-25-006569 Size: 6 KB

New Form 144 - Editas Medicine, Inc. Filed: 2025-08-29 AccNo: 0001650664-25-000130 Size: 4 KB

New Form 424B5 - Neuraxis, INC Filed: 2025-08-29 AccNo: 0001641172-25-026009 Size: 918 KB

New Form 8-K - Chemours Co Filed: 2025-08-29 AccNo: 0001627223-25-000005 Size: 247 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Best Budget Cheap Blender Models for Home Use in 2025

New Form SCHEDULE 13G - Invivyd, Inc. Filed: 2025-08-29 AccNo: 0001415889-25-023305 Size: 19 KB